Tang D, Kamitaki N, Mukamel RE, Rubinacci S, Loh PR. Patterns and drivers of 43,617 mosaic chromosomal alterations in blood. Nature genetics. 2026. doi:10.1038/s41588-026-02592-0
Publications
Owais A, Chen H, Farooq H, et al. Gene-gene interactions between a LMNA variant and common polymorphisms drive early-onset atrial fibrillation. Nature communications. 2026. doi:10.1038/s41467-026-73113-0
Kotch C, Perreault S, Power P, et al. Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma. Neuro-oncology. 2026. doi:10.1093/neuonc/noag111
Borren NZ, Paulides E, A Y Klaassen M, et al. Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multi-Strain Probiotic Supplementation. The American journal of gastroenterology. 2026. doi:10.14309/ajg.0000000000004056
Rius R, Blakes AJM, Chen Y, et al. Author Correction: Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes. Nature genetics. 2026. doi:10.1038/s41588-026-02636-5
Sandi JD, Brock-Fisher TM, Kallon TMPS, et al. Characterization of the first complete genome sequence of yellow fever virus (YFV) in Sierra Leone: Implications for public health. PLoS neglected tropical diseases. 2026;20(5):e0014354. doi:10.1371/journal.pntd.0014354
Harney É, Jewett E, Micheletti S, et al. The genetic legacy of the 17th-century colonial capital of St. Mary’s City. Current biology : CB. 2026. doi:10.1016/j.cub.2026.04.046
Nguyen DH, Tian J, Shanahan SL, et al. A tissue-scale strategy for sensing threats in barrier organs. Cell systems. 2026:101611. doi:10.1016/j.cels.2026.101611
Hou L, Li Y, Xiong X, et al. Genotype epigenome phenotype integration reveals peripheral immune contributions to type I bipolar disorder. Nature communications. 2026. doi:10.1038/s41467-026-72543-0
Garrido-Castro AC, Graham N, Li KX, et al. Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial. Nature communications. 2026. doi:10.1038/s41467-026-73085-1